ADDF-funded investigators to present research on wide range of novel approaches that will support a combination therapy and precision medicine approach NEW YORK, Oct. 17, 2023 /PRNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF) will be moderating a session, “Emerging…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.